Search
News
Powell Q3 FY2026 earnings: Record orders lift backlog to $2.4 billion
Powell Industries’ fiscal third-quarter 2026 revenue rose 9% year over year to $311.7 million, while diluted EPS increased to $1.42 from $1.32. Gross margin held nearly flat at 30.6%, supporting net income of $52.2 million. The more consequential change was in demand: new orders surged 158% to a record $934 million, lifting backlog 69% to $2.4 billion. Commercial and Other Industrial revenue grew 54% and Electric Utility revenue increased 18%, partly offset by a 49% decline in Petrochemical revenue. Management is adding capacity as it works to convert the larger backlog.
TradingKey
Mon, Aug 3
Hess Midstream Q2 2026 earnings: Lower throughput cuts revenue as free cash flow rises
Hess Midstream LP’s Q2 2026 revenue fell 3.7% year over year to $399.0 million as lower new-well activity and planned maintenance reduced throughput. Diluted EPS increased to $0.75 from $0.74, while consolidated net income declined to $173.7 million. Adjusted Free Cash Flow rose 19.5% to $231.6 million, largely reflecting a 56% reduction in capital spending after completion of a gas-compression expansion. The company reaffirmed its full-year 2026 financial and throughput guidance, although first-half averages remained below the guided throughput ranges.
TradingKey
Mon, Aug 3
EchoStar Q2 2026 earnings: A non-cash gain drives the profit swing
EchoStar’s Q2 2026 earnings showed revenue of $3.58 billion, down about 4.0% year over year, while diluted EPS swung to $24.12 from a $1.06 loss. Reported net income attributable to EchoStar reached $8.46 billion, but the result was driven primarily by a $9.73 billion non-cash deconsolidation gain; excluding its tax-affected impact, net income would have been about $49.46 million. Adjusted OIBDA rose to $681.2 million from $279.6 million even as pay-TV, wireless and broadband subscribers declined, and operating income turned positive.
TradingKey
Mon, Aug 3
Costamare Bulkers Q2 2026 Earnings: Derivative Marks Widen the Adjusted Profit Gap
Costamare Bulkers’ Q2 2026 earnings included $111.6 million of total voyage revenue, $5.2 million of GAAP net income, or $0.21 per share, and $9.8 million of adjusted net income, or $0.40 per share. The gap largely reflected a $3.7 million adjustment for derivative losses excluding realized effects. Operating cash flow was $1.3 million, while quarter-end liquidity reached $331.5 million and cash plus margin deposits exceeded debt by $108.9 million. The company also completed the Cargill trading-book transfer and agreed to sell the 2009-built Bermondi.
TradingKey
Mon, Aug 3
Kosmos Energy Q2 2026 earnings: Production growth and higher prices lift revenue
Kosmos Energy’s Q2 2026 oil and gas revenue rose 54.7% to $607.3 million, while diluted EPS improved to $0.31 from a $0.18 loss. Net production increased about 12% to 71,400 boepd as GTA ramped and new Jubilee wells came online, while production expense fell 26% to $179.4 million. Free cash flow nearly doubled to $88.9 million, and net debt declined to $2.56 billion. Updated 2026 guidance reflects the Equatorial Guinea asset sale, while hedge cash settlements reduced realized revenue despite higher reported sales.TradingKey
Mon, Aug 3
Oxford Square Q2 2026 Earnings: Realized Losses and Distributions Pressure NAV
Oxford Square Capital Corp. (OXSQ) reported Q2 2026 total investment income of $9.4 million, compared with $9.5 million a year earlier, while net investment income declined to $5.1 million, or $0.05 per share, from $5.5 million, or $0.08. NAV ended June 30 at $1.29 per share, down from $1.32 at March 31, as realized losses and distributions pressured book value. The company issued 11.3 million shares for $17.8 million of net proceeds and maintained monthly distributions of $0.035 per share for October through December.TradingKey
Fri, Jul 31
RBC Bearings Fiscal Q1 2027 Earnings: Aerospace Growth Lifts Margins
RBC Bearings’ fiscal Q1 2027 net sales rose 19.2% to $519.5 million, while diluted EPS increased to $3.20 from $2.17. Gross margin expanded to 47.7% from 44.8%, led by Aerospace & Defense sales growth of 36.9%, while acquired VACCO contributed $34.4 million of revenue. Operating cash flow reached $171.8 million. For fiscal Q2, management expects $505 million to $515 million in sales and a 45.5% to 45.75% gross margin, implying continued growth but a sequential margin decline.
TradingKey
Fri, Jul 31
InTest Q2 2026 preliminary earnings: Revenue guidance rises as margin target falls
InTest’s preliminary Q2 2026 results put revenue at approximately $35 million, above its prior $32 million to $34 million range, while gross margin was about 40% and operating expenses were estimated at $13.9 million. Unfavorable Alfamation project mix and a supply-chain delay affecting roughly $2 million of ITS revenue drove the margin shortfall. InTest raised full-year revenue guidance to $135 million-$140 million but lowered its gross-margin outlook to about 43%. It also plans a $750,000 downward revision to first-quarter gross profit tied to Alfamation ERP and inventory issues.
TradingKey
Fri, Jul 31
IES Fiscal Q3 2026 Earnings: Data Center Demand Drives 40% Revenue Growth
IES Holdings’ fiscal Q3 2026 revenue rose 40% to $1.243 billion, while diluted EPS increased to $7.57 from $3.81 and operating income advanced 60% to $178.5 million. Data center demand lifted Communications, Infrastructure Solutions, and Commercial & Industrial, more than offsetting a 6% Residential revenue decline. Backlog reached $4.53 billion, supported by expanded capacity and larger projects, while the company ended June 30 with $77.3 million in cash, $310.6 million in marketable securities, and no debt. Infrastructure acquisition investments and housing weakness remain important areas to monitor.
TradingKey
Fri, Jul 31
AbbVie Q2 2026 earnings: Immunology and neuroscience drive 10.2% revenue growth
AbbVie (NYSE: ABBV) reported Q2 2026 net revenue of $16.990 billion, up 10.2% year over year, with GAAP diluted EPS rising to $2.03 from $0.52 and adjusted diluted EPS increasing 22.9% to $3.65. Immunology revenue grew 15.1% as Skyrizi and Rinvoq more than offset Humira’s decline, while neuroscience advanced 20.3%. GAAP profitability also benefited from lower acquired IPR&D, contingent consideration expense, and tax costs. AbbVie lowered full-year adjusted EPS guidance to $13.87-$14.07 to include dilution from its proposed $10.9 billion Apogee Therapeutics acquisition.
TradingKey
Fri, Jul 31
Dominion Energy Q2 2026 earnings: Operating EPS rises as GAAP profit falls
Dominion Energy reported second-quarter 2026 operating revenue of $4.48 billion, up about 18% year over year, while GAAP diluted EPS fell to $0.37 from $0.88. Non-GAAP operating earnings increased to $712 million, or $0.79 per share, as Dominion Energy Virginia offset weaker contributions from South Carolina, Contracted Energy, and Corporate and Other. The sharp GAAP decline reflected impairment-related and regulated asset retirement charges, partly offset by nuclear decommissioning trust gains. The company reaffirmed full-year operating EPS guidance of $3.45 to $3.69.
TradingKey
Fri, Jul 31
Cboe Q2 2026 earnings: Options growth lifts net revenue 25%
Cboe Global Markets’ Q2 2026 earnings featured record net revenue of $731.6 million, up 25% year over year, and diluted EPS of $3.35, up 50%. GAAP operating margin expanded 7.4 percentage points to 65.1% as operating expenses rose only 3%, while Options net revenue climbed 30% to $473.9 million. Cboe raised its 2026 organic net revenue growth target to the mid-to-high teens and Data Vantage’s target to the low teens, kept adjusted operating expense guidance at $838 million to $853 million, and increased its capital expenditure range.
TradingKey
Fri, Jul 31
Gates Industrial Q2 2026 earnings: Higher sales support raised guidance
Gates Industrial’s Q2 2026 net sales rose 6.6% to $941.6 million, while core sales increased 4.9%. Diluted EPS climbed to $0.67 from $0.22, helped by a $78.0 million income tax benefit; adjusted EPS was $0.44. Adjusted EBITDA rose 6.1% to $211.4 million, with margin unchanged at 22.5%. Power Transmission outpaced Fluid Power on profit growth, and the company raised its full-year core sales, adjusted EBITDA and adjusted EPS guidance while leaving capital spending and free cash flow conversion targets unchanged.
TradingKey
Fri, Jul 31
Moderna Q2 2026 Earnings: Lower Costs Narrow the Net Loss
Moderna’s Q2 2026 revenue edged up to $145 million from $142 million, while GAAP loss per share narrowed to $1.97 from $2.13. Cash, cash equivalents and investments ended June at $6.9 billion. Lower R&D and SG&A spending helped reduce the quarterly net loss by 5%, and the company lowered its 2026 cost outlook while raising expected year-end liquidity. Pipeline developments were mixed: mFLUSIVA had an August 5 PDUFA date, but the Phase 3 norovirus program did not meet the interim threshold for early success.
TradingKey
Fri, Jul 31
GCL FY2026 Earnings: Revenue Growth Came With Lower Margins and a Net Loss
GCL Global Holdings’ FY2026 revenue rose 68.2% to US$238.9 million, but gross margin fell to 10.3% from 15.0% as lower-margin distribution represented more of the expanded sales base. The company recorded a US$26.2 million net loss and a diluted loss of US$0.20 per share, reversing the prior year’s profit. Cash increased to US$36.6 million, while inventory reached US$32.4 million and bank borrowings totaled about US$54.0 million. Management is prioritizing higher-margin publishing, operating efficiencies, cash conversion and lower leverage.TradingKey
Fri, Jul 31
Balchem Q2 2026 Earnings: All Three Segments Drive 11.2% Sales Growth
Balchem’s fiscal Q2 2026 net sales rose 11.2% year over year to $284.0 million, while diluted GAAP EPS increased to $1.39 from $1.17. Net earnings grew 16.6% to $44.6 million, and adjusted EBITDA advanced 12.6% to $77.9 million as all three reporting segments posted sales and operating earnings growth. Gross margin held nearly steady at 36.5%, but operating leverage and lower interest expense helped earnings outpace revenue. Free cash flow declined to $36.2 million as quarterly capital spending increased, leaving cash conversion as an important area to monitor.
TradingKey
Fri, Jul 31
Eaton Q2 2026 earnings: Organic growth lifted sales while GAAP profit fell
Eaton’s Q2 2026 earnings showed revenue of $8.53 billion, up 21% year over year, including 14% organic growth and 7% from acquisitions. Adjusted EPS rose 7% to a record $3.15, but GAAP EPS fell to $2.11 from $2.51 as acquisition and divestiture charges, intangible amortization, higher interest expense and taxes weighed on reported profit. Segment margin was 23.1%, while free cash flow increased 22% to $874 million. Eaton raised full-year organic growth and adjusted EPS guidance as Electrical and Aerospace orders and backlogs accelerated.
TradingKey
Fri, Jul 31
Newell Brands Q2 2026 Earnings: Sales Growth Returns as Margins Expand
Newell Brands’ Q2 2026 net sales rose 3.0% to $1.994 billion, while diluted EPS increased to $0.25 from $0.11. Reported operating margin improved to 14.2% from 8.8%, aided materially by approximately $126 million of pretax IEEPA tariff recoveries. Core sales grew 2.3%, led by Learning & Development, although Outdoor profitability weakened and year-to-date operating cash flow remained negative. The company raised its full-year sales, normalized margin, EPS and operating cash flow outlook.
TradingKey
Fri, Jul 31
TXNM Energy Q2 2026 Earnings: Rate Recovery and Load Growth Lift Profit
TXNM Energy’s second-quarter 2026 electric operating revenue rose 9.2% to $548.6 million, while GAAP diluted EPS increased to $0.64 from $0.22 and ongoing EPS climbed to $0.58 from $0.25. Rate relief, higher retail load, transmission revenue, and regulatory recovery at PNM and TNMP outweighed higher depreciation, property taxes, interest expense, and storage demand charges. Operating income reached $123.3 million as total operating expenses edged lower. The Blackstone acquisition agreement was extended, with closing expected in the first half of 2027 subject to remaining approvals.
TradingKey
Fri, Jul 31
Lear Q2 2026 earnings: E-Systems margins improve as cash flow rises
Lear’s Q2 2026 revenue rose 3% to $6.21 billion, while GAAP diluted EPS increased 24% to $3.79. Net income attributable to Lear reached $192.8 million, and free cash flow climbed 69% to $287.8 million. E-Systems delivered the clearest margin improvement, with its adjusted segment margin rising to 5.8% from 4.9%, while Seating’s adjusted margin held at 6.7%. Lear also raised the midpoints and narrowed most ranges in its 2026 outlook, including sales guidance of $23.54 billion to $24.01 billion.
TradingKey
Fri, Jul 31
Featured Tools
Top News
Oracle Stock Forecast: $630 Billion AI Order Backlog Awaits Revaluation, Can the Stock Continue to Recover?
New CEO Ternus Launches iPhone 18 Pro on September 9 — Can Apple Reverse Q3 China Miss Before Jackson Hole?
Micron vs. SK Hynix: As HBM Demand Continues to Surge, Which Memory Stock Deserves More Attention?
Western Digital Shares Plunge 50%: Is It the Best Time to Buy?
Cerebras Cloud Revenue Nearly Quadrupled — But Why Did the Stock Crash 17% on "Confusing" GAAP Results?
